QSS
ADVM

Quantitative Systematic Strategies’s Adverum Biotechnologies ADVM Stock Holding History

Quantitative Systematic Strategies’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,034
Closed -$416K – 595
2020
Q3 		$416K Buy
4,034
+1,070
+36% +$160K 0.07% 359
2020
Q2 		$619K Buy
2,964
+154
+5% +$27.3K 0.12% 262
2020
Q1 		$275K Sell
2,810
-949
-25% -$111K 0.23% 165
2019
Q4 		$433K Buy
3,759
+1,245
+50% +$110K 0.06% 367
2019
Q3 		$137K Buy
+2,514
New +$283K 0.03% 426
2018
Q4 		– Sell
-1,128
Closed -$68K – 679
2018
Q3 		$68K Buy
+1,128
New +$63.4K 0.01% 588
2016
Q1 		– Sell
-2,349
Closed -$222K – 407
2015
Q4 		$222K Buy
+2,349
New +$206K 0.06% 824
2015
Q2 		– Sell
-8,046
Closed -$3.21M – 498
2015
Q1 		$3.21M Buy
+8,046
New +$3.4M 0.88% 14

Other funds holding ADVM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Quantitative Systematic Strategies's ADVM Position: Q4 2020 in Review

Quantitative Systematic Strategies sold out of Adverum Biotechnologies (ADVM) in Q4 2020, closing a stake of 4,034 shares — an estimated $416K sold.

Quantitative Systematic Strategies first reported a position in ADVM in Q1 2015 and held it in 8 quarters. The position peaked at $3.21M in Q1 2015. 155 funds tracked by Wall St. Rank hold ADVM as of Q4 2020.

  • Quantitative Systematic Strategies reported no remaining Adverum Biotechnologies position as of Q4 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 4,034 Adverum Biotechnologies shares in Q4 2020, an estimated $416K.
  • Quantitative Systematic Strategies first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 8 quarters.
  • Quantitative Systematic Strategies's Adverum Biotechnologies position peaked at $3.21M in Q1 2015.
  • 155 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2020, filed 9 Feb 2021.